Skip to main content
Livermore
Livermore
ZHEN

Wealthfront Advisers LLC

SEC CIK
0001763921
Latest filing
Aug 7, 2026

CRL holding history

Charles River Laboratories International, Inc. in every 13F filed by Wealthfront Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRL overviewAll 13F holders of CRLFull Q2 2026 holdings

Shares (Q2 2026)
1,720
Value
$390.1K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of CRL by Wealthfront Advisers LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,720$390.1K<0.1%+111+6.9%AddedHolders
Q1 20261,609$277.6K<0.1%+243+17.8%AddedHolders
Q4 20251,366$272.5K<0.1%+1,366NewHolders
Q1 20250$00.0%−4,567−100.0%Sold outHolders
Q4 20244,567$843.1K<0.1%−3,613−44.2%ReducedHolders
Q3 20248,180$1.61M<0.1%−621−7.1%ReducedHolders
Q2 20248,801$1.82M<0.1%−407−4.4%ReducedHolders
Q1 20249,208$2.49M<0.1%−252−2.7%ReducedHolders
Q4 20239,460$2.24M<0.1%+8,081+586.0%AddedHolders
Q3 20231,379$270.3K<0.1%+205+17.5%AddedHolders
Q2 20231,174$246.8K<0.1%−629−34.9%ReducedHolders
Q1 20231,803$363.9K<0.1%−331−15.5%ReducedHolders
Q4 20222,134$465.0K<0.1%+285+15.4%AddedHolders
Q3 20221,849$364.0K<0.1%+464+33.5%AddedHolders
Q2 20221,385$296.0K<0.1%+333+31.7%AddedHolders
Q1 20221,052$298.0K<0.1%−4,157−79.8%ReducedHolders
Q4 20215,209$1.96M<0.1%+2,085+66.7%AddedHolders
Q3 20213,124$1.29M<0.1%+2,115+209.6%AddedHolders
Q2 20211,009$373.0K<0.1%+162+19.1%AddedHolders
Q1 2021847$245.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.